OGENNYSEPharmaceutical PreparationsFiscal year ends December 31
ORAGENICS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.42−0.01 (-2.97%)
Close on Oct 19, 2026
- Market cap
- $1.87M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
1.5%
0M of 5M shares
Institutional holders
17
2 new, 5 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
0 buys · 2 sales
Net sold $395
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Five Narrow Lane LP | 82,210 | 9.99% | 13G (passive) | Jul 2, 2025 |
| Sabby Management, LLC | 412,654 | 9.90% | 13G (passive) | Dec 31, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of OGEN | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 23,685 | 0.52% | $13.75K | −41,387 | 0.00% |
| 25 LLC | 23,160 | 0.51% | $13.45K | New | 0.00% |
| Jane Street Group, LLC | 12,771 | 0.28% | $7.41K | New | 0.00% |
| Tower Research Capital LLC (TRC) | 4,548 | 0.10% | $2.64K | – | 0.00% |
| St. Johns Investment Management Company, LLC | 1,924 | 0.04% | $1.12K | +1,724 | 0.00% |
| BlackRock, Inc. | 703 | 0.02% | $408 | – | 0.00% |
| UBS Group AG | 642 | 0.01% | $373 | −4,563 | 0.00% |
| Harbour Investments, Inc. | 34 | 0.00% | $20 | – | 0.00% |
| Wells Fargo & Company/Mn | 34 | 0.00% | $20 | – | 0.00% |
| SBI Securities Co., Ltd. | 23 | 0.00% | $13 | +12 | 0.00% |
| Adkins Seale Capital Management LLC | 3 | 0.00% | $2 | – | 0.00% |
| Royal Bank of Canada | 2 | 0.00% | $0 | +1 | 0.00% |
| Bogart Wealth, LLC | 1 | 0.00% | $1 | – | 0.00% |
| Strategic Wealth Partners, Ltd. | 1 | 0.00% | $1 | – | 0.00% |
| Farther Finance Advisors, LLC | 1 | 0.00% | $1 | – | 0.00% |
| Keating Financial Advisory Services, Inc. | 1 | 0.00% | $1 | – | 0.00% |
| Johnson Financial Group, Inc. | 1 | 0.00% | $1 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 17 | 0M | 1.5% | 2 / 3 | 2 / 5 | 0M | 0M |
| Q1 2026 | 20 | 0M | 4.2% | 11 / 2 | 1 / 9 | 0M | 0M |
| Q4 2025 | 19 | 0M | 4.8% | 5 / 5 | 0 / 2 | 0M | 0M |
| Q3 2025 | 16 | 0M | 2.7% | 4 / 1 | 5 / 5 | 0M | 0M |
| Q2 2025 | 18 | 0M | 2.3% | 18 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of OGEN | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 63,379 | 1.40% | $38.40K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| John Spencer | Chief Financial Officer | 53 | 0.00% | Jul 7, 2026 |
| Janet Huffman | CEO and CFO | 15,000 | 0.33% | Dec 15, 2025 |
| Fred Telling | Director | 948 | 0.02% | Jan 22, 2026 |
| Charles L. Pope | Director | 25,471 | 0.56% | Dec 15, 2025 |
| Natasha Giordano | Director | – | – | Dec 15, 2025 |
| John P. Gandolfo | Director | – | – | Dec 15, 2025 |
| Alan W. Dunton | Director | 25,623 | 0.57% | Dec 15, 2025 |
| Robert C. Koski | Director | 51,307 | 1.14% | Dec 15, 2025 |
| Odyssey Health, Inc. | 10% owner | 0 | – | Jun 18, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Fred Telling Director | Dec 12, 2025 | Sale | −210 | $0.94 | $197 | 948 |
| Fred Telling Director | Dec 12, 2025 | Sale | −210 | $0.94 | $197 | 34,538 |
| Odyssey Health, Inc. 10% owner | Jun 18, 2025 | Sale | −5,044 | $4.26 | $21.49K | 0 |
| Odyssey Health, Inc. 10% owner | Jun 17, 2025 | Sale | −2,000 | $4.46 | $8.92K | 5,044 |
| Odyssey Health, Inc. 10% owner | Jun 16, 2025 | Sale | −5,000 | $4.45 | $22.25K | 7,044 |
| Odyssey Health, Inc. 10% owner | Jun 13, 2025 | Sale | −5,000 | $4.27 | $21.35K | 12,044 |
| Robert C. Koski Director | Dec 11, 2024 | Conversion | +5,000 | – | – | 23,367 |
| Fred Telling Director | Dec 6, 2024 | Sale | −3,597 | $0.36 | $1.29K | 34,748 |
| Alan W. Dunton Director | Dec 6, 2024 | Sale | −66 | $0.36 | $24 | 25,623 |
| Fred Telling Director | Nov 30, 2023 | Sale | −3,500 | $3.57 | $12.50K | 38,345 |
| Robert C. Koski Director | Aug 8, 2023 | Award | +25,000 | – | – | 27,940 |
| Janet Huffman CFO, Secretary and Treasurer | Aug 8, 2023 | Award | +15,000 | – | – | 15,000 |
| Charles L. Pope Director | Aug 8, 2023 | Award | +25,000 | – | – | 25,471 |
| Alan W. Dunton Director | Aug 8, 2023 | Award | +25,000 | – | – | 25,689 |
| Robert C. Koski Director | Aug 8, 2023 | Award | +25,000 | – | – | 25,689 |
| Fred Telling Director | Aug 8, 2023 | Award | +25,000 | – | – | 41,845 |
| Kimberly M. Murphy CEO and President, Director | Aug 8, 2023 | Award | +25,000 | – | – | 25,000 |
| Robert C. Koski Director | Dec 30, 2022 | Sale | −42,357 | $0.11 | $4.66K | 1,102,295 |
| Robert C. Koski Director | Dec 29, 2022 | Sale | −36,648 | $0.11 | $4.03K | 176,191 |
| Robert C. Koski Director | Dec 15, 2022 | Sale | −140,497 | $0.18 | $25.29K | 1,144,652 |
| Robert C. Koski Director | Dec 14, 2022 | Sale | −25,000 | $0.18 | $4.50K | 1,285,149 |
| Robert C. Koski Director | Dec 14, 2022 | Sale | −4,503 | $0.18 | $811 | 1,310,149 |
| Robert C. Koski Director | Dec 9, 2022 | Sale | −48,795 | $0.20 | $9.76K | 1,314,652 |
| Robert C. Koski Director | Dec 8, 2022 | Sale | −13,036 | $0.20 | $2.61K | 1,363,447 |
| Robert C. Koski Director | Nov 30, 2022 | Sale | −200,000 | $0.19 | $38.00K | 1,376,483 |
| Robert C. Koski Director | Nov 29, 2022 | Sale | −200,000 | $0.19 | $38.00K | 1,576,483 |
| Fred Telling Director | Jun 17, 2022 | Buy | +10,084 | $0.29 | $2.92K | 1,010,000 |
| Fred Telling Director | May 24, 2022 | Buy | +78,673 | $0.29 | $22.82K | 999,916 |
| Fred Telling Director | May 23, 2022 | Buy | +3,500 | $0.29 | $1.02K | 921,243 |
| Fred Telling Director | May 20, 2022 | Buy | +65,718 | $0.28 | $18.40K | 917,743 |
| Fred Telling Director | May 19, 2022 | Buy | +56,806 | $0.28 | $15.91K | 852,025 |
| Fred Telling Director | May 18, 2022 | Buy | +15,303 | $0.26 | $3.98K | 795,219 |
| Fred Telling Director | Mar 31, 2022 | Buy | +59,053 | $0.35 | $20.67K | 779,916 |
| Fred Telling Director | Mar 30, 2022 | Buy | +124,785 | $0.36 | $44.92K | 720,863 |
| Michael O'Keefe Sullivan Interim PEO, CFO | Mar 29, 2022 | Buy | +20,000 | $0.35 | $7.00K | 34,255 |
| Robert C. Koski Director | Dec 31, 2021 | Buy | +799,100 | $0.47 | $375.58K | 1,776,483 |
| Robert C. Koski Director | Dec 30, 2021 | Buy | +200,900 | $0.45 | $90.41K | 977,383 |
| Fred Telling Director | Jun 29, 2021 | Option exercise | +156,540 | $0.48 | $75.14K | 596,078 |
| Joseph Hernandez 10% owner | Jan 14, 2021 | Sale | −870,854 | $0.98 | $853.44K | 0 |
| Joseph Hernandez 10% owner | Jan 13, 2021 | Sale | −257,510 | $0.80 | $206.01K | 870,854 |
| Joseph Hernandez 10% owner | Jan 12, 2021 | Sale | −629,707 | $0.73 | $459.69K | 1,128,364 |
| Joseph Hernandez 10% owner | Jan 11, 2021 | Sale | −441,929 | $0.77 | $340.29K | 1,758,071 |
| Joseph Hernandez 10% owner | Jan 7, 2021 | Sale | −323,997 | $0.84 | $272.16K | 2,200,000 |
| Joseph Hernandez 10% owner | Jan 6, 2021 | Sale | −1,000,000 | $0.60 | $600.00K | 2,523,997 |
| Joseph Hernandez 10% owner | Jan 5, 2021 | Sale | −500,000 | $0.58 | $290.00K | 3,523,997 |
| Joseph Hernandez 10% owner | Jan 4, 2021 | Sale | −176,003 | $0.52 | $91.52K | 4,023,997 |
| Robert C. Koski Director | Jan 2, 2021 | Gift | −30,000 | – | – | 212,839 |
| Robert C. Koski Director | Dec 22, 2020 | Sale | −310,000 | $0.43 | $133.30K | 776,483 |
| Joseph Hernandez 10% owner | Dec 2, 2020 | Sale | −5,000,000 | $0.41 | $2.05M | 4,200,000 |
| Fred Telling Director | Nov 24, 2020 | Buy | +100,000 | $0.37 | $37.00K | 439,538 |
| Robert C. Koski Director | Apr 24, 2020 | Gift | −35,000 | – | – | 242,839 |
| Robert C. Koski Director | Dec 30, 2019 | Sale | −100,000 | $0.53 | $53.00K | 1,086,483 |
| Robert C. Koski Director | Dec 27, 2019 | Sale | −100,000 | $0.52 | $52.00K | 1,186,483 |
| Alan Joslyn See Remarks, Director | Mar 25, 2019 | Buy | +66,667 | – | – | 66,667 |
| Fred Telling Director | Mar 25, 2019 | Buy | +100,000 | – | – | 339,538 |
| Thomas L. Koski 10% owner | Sep 18, 2018 | Buy | +22,000 | $0.41 | $9.02K | 277,839 |
| Thomas L. Koski 10% owner | Sep 17, 2018 | Buy | +100,000 | $0.42 | $42.00K | 255,839 |
| Thomas L. Koski 10% owner | Sep 14, 2018 | Buy | +38,860 | $0.42 | $16.32K | 147,649 |
| Thomas L. Koski 10% owner | Sep 14, 2018 | Buy | +2,000 | $0.42 | $840 | 149,649 |
| Thomas L. Koski 10% owner | Sep 14, 2018 | Buy | +100 | $0.41 | $41 | 149,749 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| W. Telling Frederick Director | Dec 12, 2025 | 210 | $192 | Dec 12, 2025 | Acquired as compensation -- Restricted Stock Units |
| Telling Frederick Director | Dec 6, 2024 | 3,597 | $1.29K | Dec 6, 2024 | Acquired as compensation -- Restricted Stock Units |
| Alan W. Dunton Director | Dec 6, 2024 | 66 | $22 | Dec 6, 2024 | Stock Award |
| W. Telling Frederick Director | Nov 30, 2023 | 3,500 | $12.53K | Nov 30, 2023 | Acquired as compensation -- Restricted Stock Units |